Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants
- PMID: 30801736
- PMCID: PMC6499698
- DOI: 10.1111/trf.15216
Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants
Abstract
Background: Enteral iron supplementation and RBC transfusions are routinely administered to very-low-birth-weight (VLBW) infants, although the potential risks of these exposures have not been adequately quantified. This study evaluated the association between the cumulative dose of enteral iron supplementation, total volume of RBCs transfused, and risk of bronchopulmonary dysplasia (BPD) in VLBW infants.
Study design and methods: Retrospective, multicenter observational cohort study in Atlanta, Georgia. Cumulative supplemental enteral iron exposure and total volume of RBCs transfused were measured until the age at assessment of BPD. Multivariable generalized linear models were used to control for confounding, and the reliability of the factors was assessed in 1000 bootstrap models.
Results: A total of 598 VLBW infants were studied. In multivariable analyses, a greater cumulative dose of supplemental enteral iron exposure was associated with an increased risk of BPD (adjusted relative risk per 50-mg increase, 1.07; 95% confidence interval [CI], 1.02-1.11; p = 0.002). Similarly, a greater volume of RBCs transfused was associated with a higher risk of BPD (adjusted relative risk per 20-mL increase, 1.05; 95% CI, 1.02-1.07; p < 0.001). Both factors were reliably associated with BPD (>50%). Volume of RBCs transfused was similar to gestational age in reliability as a risk factor for BPD (present in 100% of models) and was more reliable than mechanical ventilation at 1 week of age.
Conclusion: The cumulative dose of supplemental enteral iron exposure and total volume of RBC transfusion are both independently associated with an increased risk of BPD in VLBW infants.
© 2019 AABB.
Conflict of interest statement
Figures
Similar articles
-
Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.JAMA Pediatr. 2015 Feb;169(2):e143676. doi: 10.1001/jamapediatrics.2014.3676. Epub 2015 Feb 2. JAMA Pediatr. 2015. PMID: 25642906
-
Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns.Pediatr Res. 2023 Feb;93(3):701-707. doi: 10.1038/s41390-022-02160-2. Epub 2022 Jun 20. Pediatr Res. 2023. PMID: 35725917 Free PMC article. Clinical Trial.
-
Effects of Red Blood Cell Transfusions on the Risk of Developing Complications or Death: An Observational Study of a Cohort of Very Low Birth Weight Infants.Am J Perinatol. 2017 Jan;34(1):88-95. doi: 10.1055/s-0036-1584300. Epub 2016 Jun 1. Am J Perinatol. 2017. PMID: 27249797
-
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004863. doi: 10.1002/14651858.CD004863.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004863. doi: 10.1002/14651858.CD004863.pub3. PMID: 16856062 Updated. Review.
-
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004868. doi: 10.1002/14651858.CD004868.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004868. doi: 10.1002/14651858.CD004868.pub3. PMID: 16856064 Updated. Review.
Cited by
-
Development and validation of a novel risk classification tool for predicting long length of stay in NICU blood transfusion infants.Sci Rep. 2024 Mar 22;14(1):6877. doi: 10.1038/s41598-024-57502-3. Sci Rep. 2024. PMID: 38519538 Free PMC article.
-
Transfusion strategies for neonates: current perspectives.Ann Med Surg (Lond). 2024 Jan 23;86(3):1550-1562. doi: 10.1097/MS9.0000000000001751. eCollection 2024 Mar. Ann Med Surg (Lond). 2024. PMID: 38463073 Free PMC article. Review.
-
Hyperferritinemia among very-low-birthweight infants in Thailand: a prospective cohort study.J Perinatol. 2024 May;44(5):709-716. doi: 10.1038/s41372-023-01839-6. Epub 2023 Dec 7. J Perinatol. 2024. PMID: 38062158
-
Blood Donor Sex and Outcomes in Transfused Infants.Clin Perinatol. 2023 Dec;50(4):805-820. doi: 10.1016/j.clp.2023.08.001. Epub 2023 Sep 16. Clin Perinatol. 2023. PMID: 37866849 Review.
-
A predictive model for preterm infants with bronchopulmonary dysplasia based on ferroptosis-related lncRNAs.BMC Pulm Med. 2023 Oct 2;23(1):367. doi: 10.1186/s12890-023-02670-7. BMC Pulm Med. 2023. PMID: 37784105 Free PMC article.
References
-
- Baker RD, Greer FR, Committee on Nutrition American Academy of P. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics 2010;126: 1040–50. - PubMed
-
- Taylor TA, Kennedy KA. Randomized trial of iron supplementation versus routine iron intake in VLBW infants. Pediatrics 2013;131: e433–8. - PubMed
-
- Strauss RG. Practical issues in neonatal transfusion practice. Am J Clin Pathol 1997;107: S57–63. - PubMed
-
- Braekke K, Bechensteen AG, Halvorsen BL, Blomhoff R, Haaland K, Staff AC. Oxidative stress markers and antioxidant status after oral iron supplementation to very low birth weight infants. J Pediatr 2007;151: 23–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical